Industrivarden AB operates within the Investors sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Industrivarden AB with three other
financial institutions in Europe:
F Marc de Lacharriere Fimalac SA
sales of 358.30 million Euro [US$387.35 million]
MedCap AB (publ)
(816.92 million Swedish Kronor [US$92.88 million]
of which 74%
was Unimedic), and
Gimv Investeringsmaatschappij Voor Vlanderen NV
based in Belgium
(103.76 million Euro [US$112.18 million]
of which 36%
was Health & Care).
During the year ended December of 2016, sales at
Industrivarden AB were SEK 3.08 billion (US$349.94 million).
decrease of 8.1%
versus 2015, when the company's sales were SEK 3.35 billion.